Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas

Luis R. Lopez(Consejo Nacional de Investigaciones Científicas y Técnicas), Mario Hermsen(Instituto de Investigación Sanitaria del Principado de Asturias)
Journal of Personalized Medicine
October 18, 2023
10.3390/jpm13101504
Cited by 5

Related Papers

EGFR mutation and HPV infection in sinonasal inverted papilloma and squamous cell carcinoma
|Rhinology Journal|2020|34
Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma
|Cells|2023|5